<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="343393">
  <stage>Registered</stage>
  <submitdate>24/08/2011</submitdate>
  <approvaldate>25/08/2011</approvaldate>
  <actrnumber>ACTRN12611000914965</actrnumber>
  <trial_identification>
    <studytitle>The effect of routine reversal of neuromuscular blockade on surgical conditions for thyroid surgery</studytitle>
    <scientifictitle>The effect of routine reversal using neostigmine, of neuromuscular blockade, on neuromuscular monitoring of the laryngeal nerve during thyroid surgery- a double blinded randomised control trial</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Reversal of neuromuscular blockade during thyroid surgery</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Anaesthetics</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Surgery</conditioncode1>
      <conditioncode2>Other surgery</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Atracurium 0.4mg/kg given as an intubating dose, given intravenously as a bolus, then reversal at 30 mins with neostigmine 2.5mg and glycopyrrolate 0.4mg, intravenously as a bolus, if in the study arm</interventions>
    <comparator>Normal saline injection at 30 mins, following the intubating dose of atracurium 0.4mg/kg</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Surgical operating conditions for NIM monitor, as subjectively described by surgeon as adequate, or inadequate</outcome>
      <timepoint>30 mins after induction the study or placebo drugs will be given, the time point of NIM stimulation is when the surgeon is ready- usually 45-60 mins</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Time to stimulation using NIM moniter</outcome>
      <timepoint>At the time of stimulation with NIM moniter</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Trial of four nerve stimulation, using a peripheral nerve stimulator attached to the hand of each participant</outcome>
      <timepoint>Five mins after relaxant given</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Trial of four nerve stimulation</outcome>
      <timepoint>60 mins</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Thyroid surgery at Peninsula Health</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>100</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Allergy to atracurium
Musculoskeletal abnormality
Surgeon not using NIM stimulation intraoperatively
Recurrent laryngeal nerve injury/abnormality</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Subjects will be recruited from the thyroid surgery waiting list at Peninsula Health, and will be screened through the pre admission clinic for suitability.  Once enrolled and consented, computer generation of randomisation will occur, an independent person will prepare the study or placebo injection following instructions in a concealed envelope and will hand the syringe to the anaesthetist for injection</concealment>
    <sequence>Computer generation, will allocate individuals, then an independent person will take the allocated allotted envelope and hand this to another independent person for preparation</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1>True</masking1>
    <masking2>True</masking2>
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>30/08/2011</anticipatedstartdate>
    <actualstartdate>30/08/2011</actualstartdate>
    <anticipatedenddate />
    <actualenddate>12/07/2012</actualenddate>
    <samplesize>50</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Emma Boden</primarysponsorname>
    <primarysponsoraddress>Frankston Hospital
Hastings Road
Frankston
Victoria
3199</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Frankston Hospital</fundingname>
      <fundingaddress>Hastings Road
Frankston
Victoria
3199</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Stuart Marshall</sponsorname>
      <sponsoraddress>Frankston Hosptial
Hastings Road
Frankston
Vicotoria
3199</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Participants will receive a standard anaesthetic with- propofol induction, remifentanil induction, 2x ED 95 (intubating conditions) atracurium 0.4mg/km, sevoflurane, dexamethasone and cefazolin.
At 30 mins post induction patients will either get neostigmine/glycopyrrolate injection or saline injection prepared by an independent person, given by anaesthetist.  

Then the surgeon will determine, using the NIM stimulator whether the reversal of neuromuscular blockade is adequate.</summary>
    <trialwebsite>Nil</trialwebsite>
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Peninsula Health</ethicname>
      <ethicaddress>Frankston Hosptial
Hastings Road
Frankston
Victoria
3199</ethicaddress>
      <ethicapprovaldate />
      <hrec>HREC/11/PH/62</hrec>
      <ethicsubmitdate>18/07/2011</ethicsubmitdate>
      <ethiccountry>New Zealand</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Emma Boden</name>
      <address>Frankston Hospital
Hastings Road
Frankston
Victoria
3199</address>
      <phone>+61 397847445</phone>
      <fax />
      <email>eboden@phcn.vic.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Mr</title>
      <name>The Convener, Peninsula Health Human Research and Ethics Comittee</name>
      <address>Frankston Hospital
Hastings Road
Frankston
Victoria
3199</address>
      <phone>+61 397881473</phone>
      <fax />
      <email>researchethics@phcn.vic.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Emma Boden</name>
      <address>Frankston Hospital
Hastings Road
Frankston
Victoria
3199</address>
      <phone>+61 397847445</phone>
      <fax />
      <email>emmajboden@gmail.com</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Stuart Marshall</name>
      <address>Frankston Hospital
Hastings Road
Frankston
Victoria 3199</address>
      <phone>+61397881473</phone>
      <fax />
      <email>smarshall@phcn.vic.gov.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>